June highlights shorter CAR T culture times at SITC

In a presentation at the Society for Immunotherapy of Cancer (SITC) meeting Friday, CAR T cell pioneer Carl June highlighted preclinical data from University of Pennsylvania suggesting CAR T cell therapies could require as little as three days of culture time, and shorter cultures could actually improve the cells' antitumor effects in vivo.

Shorter culture times for clinical CAR T cell products would cut waiting periods for patients and reduce the cost and labor required to produce the therapies, which could increase manufacturing efficiency and patient access...